| My Account | Subscribe | Contact Us | Donate |
Home
- Kris Freeman Skis for Olympic Gold
- Good Insulin Injection Practices
- Etiquette for People without Diabetes
- Diabetes Technology and Intimacy
- An American in the UK: Healthcare for Type 1s
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Complications & Care Articles
Researchers found that the type 2s as a group had a 19 percent lower incidence of prostate cancer than non-diabetics. There were some ethnic variations: European-Americans ran a 35 percent lower risk of prostate cancer, while African-Americans had an 11 percent reduced risk.
Good News: Type 2 Diabetes Seems to Lower the Risk of Prostate Cancer
Finally some good news!
People with type 2 diabetes are pounded daily by reports of the increased health risks their disease poses. Sometimes, though, the news from the research front is reassuring: Scientists at the Harlyne Norris Research Center in Los Angeles report that type 2 men are at less risk of developing prostate cancer than men without diabetes.
The study looked at 86,303 men divided among five ethnic groups: African-American, European-American, Japanese-American, Latino, and Native Hawaiian. Of the total group, 5,941 men had prostate cancer.
However, researchers found that the type 2s as a group had a 19 percent lower incidence of prostate cancer than non-diabetics. There were some ethnic variations: European-Americans ran a 35 percent lower risk of prostate cancer, while African-Americans had an 11 percent reduced risk.
Scientists found that antigens specific to the prostate gland were lower in men with diabetes than in non-diabetics. The findings suggest that diabetes confers some sort of protection against prostate cancer. The next step, say researchers, is to discover what that factor is and to determine why it manifests itself differently depending upon ethnicity.
Other than skin cancer, prostate cancer is the most common cancer among American men. Last year, according to American Cancer Society estimates, 186,000 new cases of the cancer were diagnosed in the United States.
About one in six men will be diagnosed with the cancer in his lifetime. Because the cancer is extremely slow growing and highly treatable, however, only one in 35 men will die from it. Current statistics show that with treatment, the five-year survival rate is 100 percent; the 10-year survival rate is 91 percent; and the 15-year survival rate is 76 percent.
Categories: Complications & Care, Health Research, Type 2 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
1 comment -
Apr 10, 2009 -
Email to a Friend
Send a link to this page to your friends and colleagues.